Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
2.
Cutis ; 107(5): 249-252, 2021 May.
Article in English | MEDLINE | ID: mdl-34288852

ABSTRACT

Mohs micrographic surgery (MMS) entails multiple time-consuming surgical and histological examinations for each patient. Efficient communication is key in improving clinic flow, and we surveyed members of the American College of Mohs Surgery to evaluate the efficacy of different techniques utilized by Mohs surgeons across the nation.


Subject(s)
Mohs Surgery , Skin Neoplasms , Communication , Humans , Patient Satisfaction , Skin Neoplasms/surgery , Surveys and Questionnaires
3.
Dermatol Surg ; 46(12): 1560-1563, 2020 12.
Article in English | MEDLINE | ID: mdl-32604236

ABSTRACT

BACKGROUND: There is limited data on the risk of perioperative myocardial infarctions (MIs) in patients with a recent MI who undergo dermatologic surgeries. OBJECTIVE: Present the recommendations of dermatologic surgeons and cardiologists to determine the safety of dermatologic surgeries after a recent MI. METHODS: An electronic survey was distributed to Mohs surgeons and cardiologists to infer the risk of major adverse cardiac events (MACE) inherent to dermatologic surgery and determine timing of dermatologic surgery in patients with a recent MI. RESULTS: One hundred twenty Mohs surgeons and 30 cardiologists were surveyed. Ninety-seven percent of cardiologists and 87% of Mohs surgeons deemed cutaneous excisions and Mohs micrographic surgery as low-risk procedures with less than one-percent chance of MACE. Seventy-seven percent of cardiologists and 46% of Mohs surgeons stated dermatologic surgery should either not be delayed or be delayed up to 1 month after an MI. Responses between cardiologists and Mohs surgeons did not significantly differ. CONCLUSION: A preponderance of surveyed experts believe that most dermatologic surgeries may be safely performed in patients with a history of an MI within 1 month. The decision to implement urgent dermatologic surgery in patients with a recent MI should account for all clinically significant factors.


Subject(s)
Clinical Decision-Making , Mohs Surgery/adverse effects , Myocardial Infarction/complications , Postoperative Complications/prevention & control , Time-to-Treatment/standards , Cardiologists/statistics & numerical data , Dermatology/statistics & numerical data , Expert Testimony/statistics & numerical data , Humans , Mohs Surgery/standards , Myocardial Infarction/prevention & control , Postoperative Complications/etiology , Practice Guidelines as Topic , Recurrence , Surgeons/statistics & numerical data , Surveys and Questionnaires/statistics & numerical data , Time Factors , Time-to-Treatment/statistics & numerical data
4.
Dermatol Surg ; 46(5): 581-585, 2020 05.
Article in English | MEDLINE | ID: mdl-31567550

ABSTRACT

BACKGROUND: The incidence of reactions to epinephrine-containing local anesthetics in Mohs micrographic surgery (MMS) has not been established. OBJECTIVE: To estimate the incidence of epinephrine-induced reactions from local anesthetics in patients who undergo MMS for the removal of cutaneous malignancies. METHODS: From 2016 to 2018, 200 MMS patients were recruited from the authors' surgical center. Assessments were obtained throughout the entirety of the Mohs cases during a single visit. RESULTS: This study estimated the incidence of epinephrine reactions in patients who undergo MMS to be 2.0% (95% confidence interval: 0.1%-3.9%). No relationship between epinephrine dose and incidence of adverse effects was found. Patient age was a significant risk factor for the development of an epinephrine reaction. CONCLUSION: Systemic reactions to epinephrine from local anesthetics are an infrequent adverse event in MMS cases. The data suggest that the absolute dose of local anesthetic with epinephrine does not correlate with the risk of developing an epinephrine reaction. Older age seems to have a protective effect.


Subject(s)
Anesthetics, Local/adverse effects , Drug-Related Side Effects and Adverse Reactions/epidemiology , Epinephrine/adverse effects , Mohs Surgery , Aged , Female , Humans , Incidence , Male , Oklahoma/epidemiology
5.
J Am Acad Dermatol ; 82(3): 700-708, 2020 Mar.
Article in English | MEDLINE | ID: mdl-31756403

ABSTRACT

BACKGROUND: Opioid overprescribing is a major contributor to the opioid crisis. The lack of procedure-specific guidelines contributes to the vast differences in prescribing practices. OBJECTIVE: To create opioid-prescribing consensus guidelines for common dermatologic procedures. METHODS: We used a 4-step modified Delphi method to conduct a systematic discussion among a panel of dermatologists in the fields of general dermatology, dermatologic surgery, and cosmetics/phlebology to develop opioid prescribing guidelines for some of the most common dermatologic procedural scenarios. Guidelines were developed for opioid-naive patients undergoing routine procedures. Opioid tablets were defined as oxycodone 5-mg oral equivalents. RESULTS: Postoperative pain after most uncomplicated procedures (76%) can be adequately managed with acetaminophen and/or ibuprofen. Group consensus identified no specific dermatologic scenario that routinely requires more than 15 oxycodone 5-mg oral equivalents to manage postoperative pain. Group consensus found that 23% of the procedural scenarios routinely require 1 to 10 opioid tablets, and only 1 routinely requires 1 to 15 opioid tablets. LIMITATIONS: These recommendations are based on expert consensus in lieu of quality evidence-based outcomes research. These recommendations must be individualized to accommodate patients' comorbidities. CONCLUSIONS: Procedure-specific opioid prescribing guidelines may serve as a foundation to produce effective and responsible postoperative pain management strategies after dermatologic interventions.


Subject(s)
Analgesics, Opioid/therapeutic use , Dermatology , Drug Prescriptions/standards , Pain, Postoperative/drug therapy , Practice Patterns, Physicians' , Dermatologic Surgical Procedures , Female , Humans , Male , Practice Guidelines as Topic
8.
Transpl Infect Dis ; 21(2): e13036, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30548559

ABSTRACT

We present a case of a 15-year-old girl with an allogenic renal transplant secondary to chronic glomerulonephritis of unknown etiology who presented with treatment refractory molluscum contagiosum of the lower extremities and perineum. Treatment of mollusca with pulsed dye laser resulted in a clinically significant and sustained response. To our knowledge, this is the first report of a successful treatment of molluscum contagiosum with pulsed dye laser in the setting of a renal transplant.


Subject(s)
Kidney Transplantation/adverse effects , Lasers, Dye/therapeutic use , Molluscum Contagiosum/therapy , Adolescent , Chronic Disease , Female , Glomerulonephritis/complications , Humans , Immunocompromised Host , Molluscum Contagiosum/diagnosis , Skin/pathology , Skin/virology , Transplantation, Homologous/adverse effects , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...